niman wrote:
Isolate name:
A/New York/10/2012
Isolate ID:
EPI_ISL_120298
Passage details/history:
C2
Type:
A / H1N1
Lineage:
pdm09
Sample information
Collection date:
2012-03-27
Host
Human
Additional host information:
Zip code:
Patient status:
Last vaccinated:
In-vivo pathogenicity test:
Location:
United States / New York
Additional location information:
Patient age:
Gender:
Outbreak:
Treatment:
Specimen source:
Institute information
Originating lab:
New York State Department of Health
Sample ID given by the sample provider:
4924 ORIGINAL
Address:
New York State Department of Health
Wadsworth Center-David Axelrod Institute 120 New Scotland Ave
Albany, 12208
United States
Submitting lab:
Centers for Disease Control and Prevention
Sample ID given by the submitting laboratory:
2012786111
Authors:
Address:
Centers for Disease Control and Prevention
WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Influenza Division
1600 Clifton Road, N.E.
Atlanta, GA 30333
United States
Publication
Publication
In vivo antiviral resistance
Unspecified Genotype Phenotype
Antiviral resistance tested by unknown method
Adamantanes:
Unknown
Oseltamivir:
Unknown
Zanamivir:
Unknown
Peramivir:
Unknown
Other:
Unknown
Antiviral resistance tested by sequence prediction
Adamantanes:
Unknown
Oseltamivir:
Unknown
Zanamivir:
Unknown
Peramivir:
Unknown
Other:
Unknown
Antiviral resistance tested by experimental procedures
Adamantanes:
Unknown
Oseltamivir:
Resistant
Zanamivir:
Sensitive
Peramivir:
Unknown
Other:
Unknown
Additional information
Antigenic characterization:
A/CALIFORNIA/07/2009-LIKE (H1N1)pdm09
Note:
Sequence
segment identifier length accession # INSDC Sequence
HA 2012786111_216467_v1_4 1701 EPI372990
NA 2012786111_216467_v1_6 1410 EPI372989
MP 2012786111_216467_v1_7 982 EPI372988
Isolate name:
A/Texas/49/2012
Isolate ID:
EPI_ISL_120298
Passage details/history:
C2
Type:
A / H1N1
Lineage:
pdm09
Sample information
Collection date:
2012-03-27
Host
Human
Additional host information:
Zip code:
Patient status:
Last vaccinated:
In-vivo pathogenicity test:
Location:
United States / Texas
Additional location information:
Patient age:
Gender:
Outbreak:
Treatment:
Specimen source:
Institute information
Originating lab:
New York State Department of Health
Sample ID given by the sample provider:
4924 ORIGINAL
Address:
New York State Department of Health
Wadsworth Center-David Axelrod Institute 120 New Scotland Ave
Albany, 12208
United States
Submitting lab:
Centers for Disease Control and Prevention
Sample ID given by the submitting laboratory:
2012786111
Authors:
Address:
Centers for Disease Control and Prevention
WHO Collaborating Center for Surveillance, Epidemiology and Control of Influenza, Influenza Division
1600 Clifton Road, N.E.
Atlanta, GA 30333
United States
Publication
Publication
In vivo antiviral resistance
Unspecified Genotype Phenotype
Antiviral resistance tested by unknown method
Adamantanes:
Unknown
Oseltamivir:
Unknown
Zanamivir:
Unknown
Peramivir:
Unknown
Other:
Unknown
Antiviral resistance tested by sequence prediction
Adamantanes:
Unknown
Oseltamivir:
Unknown
Zanamivir:
Unknown
Peramivir:
Unknown
Other:
Unknown
Antiviral resistance tested by experimental procedures
Adamantanes:
Unknown
Oseltamivir:
Resistant
Zanamivir:
Sensitive
Peramivir:
Unknown
Other:
Unknown
Additional information
Antigenic characterization:
A/CALIFORNIA/07/2009-LIKE (H1N1)pdm09
Note:
Sequence
segment identifier length accession # INSDC Sequence
HA 2012786111_216467_v1_4 1701 EPI372990
NA 2012786111_216467_v1_6 1410 EPI372989
MP 2012786111_216467_v1_7 982 EPI372988